Zhavoronkov quotes a speaker calling Mounjaro one of the best molecules humans have made, alongside Novo's semaglutide data at the aging conference.
Recap by typeshit. Post by Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs) on X.
PHL17 shares findings that people on Ozempic and similar drugs are cutting alcohol spending at bars, restaurants and home.
Omer Raheem says he presented his team's work on GLP-1 therapies past weight loss at the ISSM Journals Webinar 2026.
The rundown covers CagriSema, retatrutide, MariTide, VK2735 and Roche's enicepatide, which the company says cut weight by 15.5% on average in a mid-stage trial.
Zhavoronkov links recorded ARDD 2026 sessions, among them Lilly's Kevin Duffin speaking on tirzepatide and aging clocks.
Saudi sources describe progress on making semaglutide locally, while Novo says only that it is exploring opportunities and gives no timeline.
A US judge turned down Novo's request to halt Lilly's Zepbound advertising while the false advertising dispute continues.
Loading…